Charis Eng Singapore-born physician and geneticist
Eng, Charis, 1962-
Eng, Charis
Eng, Charis, 1962-2024
إنج، كاريس، 1962-
VIAF ID: 91221975 (Personal)
Permalink: http://viaf.org/viaf/91221975
Preferred Forms
-
100 0 _
‡a
Charis Eng
‡c
Singapore-born physician and geneticist
-
200 _ | ‡a Eng ‡b Charis ‡f 1962-....
-
100 1 _ ‡a Eng, Charis (sparse)
-
100 1 _ ‡a Eng, Charis
-
100 1 _ ‡a Eng, Charis ‡d (1962- ).
-
100 1 _
‡a
Eng, Charis
‡d
1962-
-
100 1 _
‡a
Eng, Charis
‡d
1962-
-
100 1 _ ‡a Eng, Charis, ‡d 1962-
-
100 1 _
‡a
Eng, Charis,
‡d
1962-
-
100 1 _ ‡a Eng, Charis, ‡d 1962-
-
100 1 _ ‡a Eng, Charis, ‡d 1962-2024
-
100 1 _ ‡a إنج، كاريس، ‡d 1962-
4xx's: Alternate Name Forms (5)
5xx's: Related Names (3)
- 510 2 _
‡a
Cleveland Clinic Foundation
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 551 _ _
‡a
Singapur
‡4
ortg
‡4
https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _
‡a
University of Chicago
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
Works
| Title | Sources |
|---|---|
| Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. |
|
| Genetic disorders of endocrine neoplasia, c2000: |
|
| Genomic medicine : principles and practice |
|
| Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer. |
|
| Heritable clustering and pathway discovery in breast cancer integrating epigenetic and phenotypic data |
|
| High Frequency of Large Gene Deletions and Rearrangements in Lynch Syndrome–Back to the Future? |
|
| High Frequency of Loss of Heterozygosity in Imprinted, Compared with Nonimprinted, Genomic Regions in Follicular Thyroid Carcinomas and Atypical Adenomas |
|
| High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma |
|
| Highly penetrant hereditary cancer syndromes. |
|
| Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study |
|
| How to spot heritable breast cancer: a primary care physician's guide |
|
| Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer |
|
| Hunting for cancer in the microbial jungle |
|
| Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma |
|
| Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cells |
|
| IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma |
|
| Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells |
|
| Immunotherapeutic target expression on breast tumors can be amplified by hormone receptor antagonism: a novel strategy for enhancing efficacy of targeted immunotherapy |
|
| Impact of an embedded genetic counselor on breast cancer treatment |
|
| Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients |
|
| Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1 |
|
| Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. |
|
| Implementing genomic medicine in the clinic: the future is here |
|
| Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells |
|
| Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes |
|
| Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone |
|
| Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes |
|
| Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes. |
|
| Integrative genomic analysis reveals extended germline homozygosity with lung cancer risk in the PLCO cohort |
|
| International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers |
|
| International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation |
|
| Interpretation of Genetic Test Results for Hereditary Nonpolyposis Colorectal Cancer |
|
| Interview |
|
| Into the eye of the storm: breast cancer's somatic mutation landscape points to DNA damage and repair |
|
| Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset |
|
| Investigating the Link between Lynch Syndrome and Breast Cancer |
|
| Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma |
|
| Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. |
|
| KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cells |
|
| Laparoscopic Organ-Sparing Resection of Von Hippel-Lindau Disease-Associated Pancreatic Neuroendocrine Tumors |
|
| Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma |
|
| Largescale population genomics versus deep phenotyping: Brute force or elegant pragmatism towards precision medicine |
|
| LEARNING TO DETECT BRAIN LESIONS FROM NOISY ANNOTATIONS |
|
| Lessons learnt from outstanding mid-career women in endocrine cancer research. |
|
| Lhermitte-Duclos disease caused by a novel germline PTEN mutation R173P in a patient presenting with psychosis |
|
| Lifetime cancer risks in individuals with germline PTEN mutations. |
|
| Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting |
|
| Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes |
|
| Long-chain L 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency does not appear to be the primary cause of lipid myopathy in patients with Bannayan-Riley-Ruvalcaba syndrome (BRRS) |
|
| Long-term Outcome in a Patient With Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia |
|
| Long-term prognosis of patients with pediatric pheochromocytoma. |
|
| Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions |
|
| Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer |
|
| Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions |
|
| Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma |
|
| Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue |
|
| Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature |
|
| Max Schottelius: Pioneer in Pheochromocytoma. |
|
| Medullary thyroid cancer: management guidelines of the American Thyroid Association |
|
| Mendelian genetics of rare—and not so rare—cancers |
|
| Metabolic stress regulates genome-wide transcription in a PTEN-dependent manner |
|
| Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer |
|
| Microbiomes of Inflammatory Thoracic Aortic Aneurysms Due to Giant Cell Arteritis and Clinically Isolated Aortitis Differ From Those of Non-Inflammatory Aneurysms |
|
| Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas. |
|
| Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease |
|
| Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma |
|
| Microenvironmental protection in diffuse large-B-cell lymphoma |
|
| Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma |
|
| Mismatch Repair Deficiency in Colorectal Cancers: Is Somatic Genomic Testing the Grab-Bag for All Answers? |
|
| Missense mutation in the PTEN promoter of a patient with hemifacial hyperplasia. |
|
| The molecualr genetics of the ... 1986 |
|
| Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease |
|
| Molecular characterisation of a common SDHB deletion in paraganglioma patients. |
|
| Molecular classification of parathyroid neoplasia by gene expression profiling |
|
| Molecular classification of the inherited hamartoma polyposis syndromes: clearing the muddied waters |
|
| Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19 |
|
| Multiple Tumors in a Child with Germ-Line Mutations inTP53andPTEN |
|
| Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors |
|
| Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome) |
|
| Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma |
|
| Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes |
|
| Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation |
|
| A practical guide to human cancer genetics |
|
| The PTEN family |
|
